Your browser doesn't support javascript.
loading
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination.
Resál, Tamás; Bacsur, Péter; Horváth, Miklós; Szántó, Kata; Rutka, Mariann; Bálint, Anita; Fábián, Anna; Bor, Renáta; Szepes, Zoltán; Fekete, János; Farkas, Klaudia; Miheller, Pál; Molnár, Tamás.
Afiliación
  • Resál T; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Bacsur P; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Horváth M; Department of Surgery and Interventional Gastroenterology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Szántó K; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Rutka M; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Bálint A; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Fábián A; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Bor R; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Szepes Z; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Fekete J; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.
  • Farkas K; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Miheller P; Department of Surgery and Interventional Gastroenterology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Molnár T; Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Kálvária Avenue 57, Szeged, H-6720, Hungary.
Therap Adv Gastroenterol ; 16: 17562848231183529, 2023.
Article en En | MEDLINE | ID: mdl-37461738
Adjustment of COVID-19 vaccination to adalimumab trough level is considerable due to the reduced serological response. mRNA vaccination should be preferred in case of IBD patients with an equal durability of anti-SARS-CoV-2 level of subjects and healthy control participants.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Hungria